Lederer & Associates Investment Counsel’s Celgene Corp CELG Stock Holding History

Lederer & Associates Investment Counsel’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9,168	Closed	-$588K	–	90
2018 Q4	$588K	Sell	9,168 -8,742	-49%	-$645K	0.63%	51
2018 Q3	$1.6M	Sell	17,910 -10	-0.1%	-$884	1.35%	34
2018 Q2	$1.42M	Buy	17,920 +225	+1%	+$18.7K	1.28%	37
2018 Q1	$1.58M	Sell	17,695 -50	-0.3%	-$4.8K	1.42%	34
2017 Q4	$1.85M	Buy	17,745 +3,246	+22%	+$366K	1.66%	27
2017 Q3	$2.11M	Sell	14,499 -631	-4%	-$85.9K	2.02%	16
2017 Q2	$1.97M	Buy	15,130 +75	+0.5%	+$9.19K	1.89%	19
2017 Q1	$1.87M	Buy	15,055 +680	+5%	+$81.4K	1.76%	21
2016 Q4	$1.66M	Buy	+14,375	New	+$1.6M	1.65%	28

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lederer & Associates Investment Counsel's CELG Position: Q1 2019 in Review

Lederer & Associates Investment Counsel sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 9,168 shares — an estimated $588K sold.

Lederer & Associates Investment Counsel first reported a position in CELG in Q4 2016 and held it in 9 quarters. The position peaked at $2.11M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

Lederer & Associates Investment Counsel reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
Lederer & Associates Investment Counsel sold 9,168 Celgene Corp shares in Q1 2019, an estimated $588K.
Lederer & Associates Investment Counsel first reported a position in Celgene Corp in Q4 2016 and held it in 9 quarters.
Lederer & Associates Investment Counsel's Celgene Corp position peaked at $2.11M in Q3 2017.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Lederer & Associates Investment Counsel's 13F filing for Q1 2019, filed 12 Apr 2019.